HALEOS LABS per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹52.27₹57.26₹66.51₹30.08₹37.92
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹52.27₹57.26₹66.51₹30.08₹37.92
₹706.34₹706.34₹650.15₹584.84₹557.71
₹1,072.44₹1,104.07₹1,140.22₹1,012.00₹1,043.76
—₹123.12₹112.64₹80.39₹48.61
−₹68.27−₹68.27₹61.87₹11.37−₹111.98
—₹1.50₹1.50₹1.50₹1.50
0.30.30.30.30.3
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

HALEOSLABS₹1,450.60

HALEOS LABS LIMITED

· Pharma & Health
₹ CrorePeersALBERTDAVDVALIANTLABMEDICOMEDICAMEQZIMLABAAREYDRUGSNECLIFEANUHPHRMcap ₹439 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS37.9230.0866.5157.2652.27
Diluted EPS37.9230.0866.5157.2652.27
Book Value per Share557.71584.84650.15706.34706.34
Revenue per Share1,043.761,012.001,140.221,104.071,072.44
Cash Flow per Share48.6180.39112.64123.12—
Free Cash Flow per Share-111.9811.3761.87-68.27-68.27
Dividends per Share1.501.501.501.50—
Shares Outstanding (cr)0.30.30.30.30.3
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.